Muleta, Janice .

HRN: 23-11-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2025
AMPICILLIN 1GM (VIAL)
01/12/2025
01/13/2025
IVT
2g
Q6hrs
PROM Thickly MSAF
Waiting Final Action 
01/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/12/2025
01/13/2025
IVT
500mg
Q8hrs
PROM Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: